Total neoadjuvant therapy in rectal cancer: the evidence and expectations
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Total neoadjuvant therapy in rectal cancer: the evidence and expectations
Authors
Keywords
-
Journal
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Volume -, Issue -, Pages 104196
Publisher
Elsevier BV
Online
2023-11-04
DOI
10.1016/j.critrevonc.2023.104196
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Locoregional Failure During and After Short-course Radiotherapy followed by Chemotherapy and Surgery Compared to Long-course Chemoradiotherapy and Surgery – A Five-year Follow-up of the RAPIDO Trial
- (2023) Esmée A. Dijkstra et al. ANNALS OF SURGERY
- Organ preservation and total neoadjuvant therapy for rectal cancer: Investigating long-course chemoradiation versus short-course radiation therapy.
- (2023) Paul Bernard Romesser et al. JOURNAL OF CLINICAL ONCOLOGY
- Does the Gain of Total Neoadjuvant Therapy Outweigh the Harm in Rectal Cancer? Importance of the ATRESS (neoAdjuvant Therapy-RElated Shortening of Survival) Phenomenon: A Systematic Review
- (2023) Joanna Socha et al. Cancers
- Total neoadjuvant therapy for rectal cancer: a guide for surgeons
- (2023) Garrett G.R.J. Johnson et al. CANADIAN JOURNAL OF SURGERY
- Risk and location of distant metastases in patients with locally advanced rectal cancer after total neoadjuvant treatment or chemoradiotherapy in the RAPIDO trial
- (2023) Renu R. Bahadoer et al. EUROPEAN JOURNAL OF CANCER
- Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER PRODIGE 23): Health-related quality of life longitudinal analysis
- (2023) Caroline Bascoul-Mollevi et al. EUROPEAN JOURNAL OF CANCER
- Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: 7-year results of PRODIGE 23 phase III trial, a UNICANCER GI trial.
- (2023) Thierry Conroy et al. JOURNAL OF CLINICAL ONCOLOGY
- Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048)
- (2023) Ethan Basch et al. JOURNAL OF CLINICAL ONCOLOGY
- Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study
- (2023) John H Strickler et al. LANCET ONCOLOGY
- Preoperative Treatment of Locally Advanced Rectal Cancer
- (2023) Deborah Schrag et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2–cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial
- (2023) Jean-Pierre Gerard et al. Lancet Gastroenterology & Hepatology
- Efficacy of immunotherapy in mismatch repair-deficient advanced colorectal cancer in routine clinical practice. An AGEO study
- (2023) E. Alouani et al. ESMO Open
- Short-Course Radiation Therapy and the RAPIDO Trial: Too Short, Too Soon?
- (2023) Krishan R. Jethwa et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Is short-course radiotherapy and total neoadjuvant therapy the new standard of care in locally advanced rectal cancer? A sensitivity analysis of the RAPIDO clinical trial
- (2022) P. Jimenez-Fonseca et al. ANNALS OF ONCOLOGY
- Nonoperative Management for Rectal Cancer
- (2022) Felipe F. Quezada-Diaz et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer – The RAPIDO trial
- (2022) Esmée A. Dijkstra et al. RADIOTHERAPY AND ONCOLOGY
- Total neoadjuvant therapy for the treatment of locally advanced rectal cancer: a systematic minireview
- (2022) Andrea M. Guida et al. Biology Direct
- Comprehensive assessment of actionable genomic alterations in primary colorectal carcinoma using targeted next-generation sequencing
- (2022) Yi-Hua Jan et al. BRITISH JOURNAL OF CANCER
- STAR-TREC phase II: Can we save the rectum by watchful waiting or transanal surgery following (chemo)radiotherapy versus total mesorectal excision for early rectal cancer?
- (2022) Simon Parkinson Bach et al. JOURNAL OF CLINICAL ONCOLOGY
- Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices
- (2022) Midhun Malla et al. JOURNAL OF CLINICAL ONCOLOGY
- PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer
- (2022) Andrea Cercek et al. NEW ENGLAND JOURNAL OF MEDICINE
- Non-Operative Management of Patients with Rectal Cancer: Lessons Learnt from the OPRA Trial
- (2022) Paolo Goffredo et al. Cancers
- Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
- (2022) A. Cervantes et al. ANNALS OF ONCOLOGY
- LBA7 Neoadjuvant immune checkpoint inhibition in locally advanced MMR-deficient colon cancer: The NICHE-2 study
- (2022) M. Chalabi et al. ANNALS OF ONCOLOGY
- DPYD and TYMS polymorphisms as predictors of 5 fluorouracil toxicity in colorectal cancer patients
- (2022) Yassine Khalij et al. JOURNAL OF CHEMOTHERAPY
- Treatment of Metastatic Colorectal Cancer: ASCO Guideline
- (2022) Van K. Morris et al. JOURNAL OF CLINICAL ONCOLOGY
- Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): short-term outcomes of a multicentre randomised controlled trial
- (2022) Qingyang Feng et al. Lancet Gastroenterology & Hepatology
- A Dynamic Clinical Calculator for Estimating Conditional Recurrence-Free Survival After Total Neoadjuvant Therapy for Rectal Cancer and Either Surgery or Watch-and-Wait Management
- (2022) Martin R. Weiser et al. JAMA Network Open
- Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Metaanalysis of Oncological and Operative Outcomes
- (2021) Joseph C. Kong et al. ANNALS OF SURGICAL ONCOLOGY
- Nonoperative Rectal Cancer Management With Short-Course Radiation Followed by Chemotherapy: A Nonrandomized Control Trial
- (2021) Hyun Kim et al. Clinical Colorectal Cancer
- Cancer statistics for the year 2020: An overview
- (2021) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial
- (2021) Thierry Conroy et al. LANCET ONCOLOGY
- Total neoadjuvant therapy ( TNT ) versus standard neoadjuvant chemoradiotherapy for locally advanced rectal cancer: a systematic review and meta‐analysis
- (2021) Shuang Liu et al. ONCOLOGIST
- Pathogenic DPYD variants and treatment‐related mortality in patients receiving fluoropyrimidine chemotherapy: A systematic review and meta‐analysis
- (2021) Bhavina B. Sharma et al. ONCOLOGIST
- Current Therapeutic Strategies in BRAF-Mutant Metastatic Colorectal Cancer
- (2021) Elisa Grassi et al. Frontiers in Oncology
- Strategies to tackle RAS-mutated metastatic colorectal cancer
- (2021) G. Patelli et al. ESMO Open
- Association of Delayed Surgery With Oncologic Long-term Outcomes in Patients With Locally Advanced Rectal Cancer Not Responding to Preoperative Chemoradiation
- (2021) Simona Deidda et al. JAMA Surgery
- Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer
- (2021) Emmanouil Fokas et al. JAMA Oncology
- Debating Pros and Cons of Total Neoadjuvant Therapy in Rectal Cancer
- (2021) Francesco Sclafani et al. Cancers
- Clinical Complete Response in Patients With Rectal Adenocarcinoma Treated With Short-Course Radiation Therapy and Nonoperative Management
- (2021) Re-I Chin et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial
- (2020) John A Bridgewater et al. LANCET ONCOLOGY
- A Randomized Phase II Study of Perioperative Chemotherapy Plus Bevacizumab Versus Postoperative Chemotherapy Plus Bevacizumab in Patients With Upfront Resectable Hepatic Colorectal Metastases
- (2020) You Jin Chun et al. Clinical Colorectal Cancer
- Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers
- (2020) Myriam Chalabi et al. NATURE MEDICINE
- P-14 Dose escalated short-course radiotherapy in rectal cancers: Is this the way forward?
- (2020) D. Chakrabarti et al. ANNALS OF ONCOLOGY
- 5‐Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes
- (2020) Sabrina Blondy et al. CANCER SCIENCE
- ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper
- (2020) Arvind Dasari et al. Nature Reviews Clinical Oncology
- LBA21 Neoadjuvant mFOLFIRINOX and preoperative chemoradiation (CRT) versus preoperative CRT in patients with T3-4 rectal cancer: Surgical and quality of life results of PRODIGE 23 phase III trial
- (2020) C. Borg et al. ANNALS OF ONCOLOGY
- Radiation Therapy for Rectal Cancer: Executive Summary of an ASTRO Clinical Practice Guideline
- (2020) Jennifer Y. Wo et al. Practical Radiation Oncology
- Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial
- (2020) Renu R Bahadoer et al. LANCET ONCOLOGY
- Total Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer
- (2020) Anup Kasi et al. JAMA Network Open
- Nonsurgical Management of Rectal Cancer
- (2019) Mehmet Akce et al. Journal of Oncology Practice
- ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach
- (2019) C Luchini et al. ANNALS OF ONCOLOGY
- Role of the Interval from Completion of Neoadjuvant Therapy to Surgery in Postoperative Morbidity in Patients with Locally Advanced Rectal Cancer
- (2019) Campbell S. D. Roxburgh et al. ANNALS OF SURGICAL ONCOLOGY
- Efficacy And Safety Of Two Neoadjuvant Strategies With Bevacizumab In Mri-Defined Locally Advanced T3 Resectable Rectal Cancer: Final Results Of A Randomized, Non Comparative Phase Ii Inova Study
- (2019) Christophe Borg et al. Clinical Colorectal Cancer
- Novel imaging techniques of rectal cancer: what do radiomics and radiogenomics have to offer? A literature review
- (2019) Natally Horvat et al. Abdominal Radiology
- Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12
- (2019) Emmanouil Fokas et al. JOURNAL OF CLINICAL ONCOLOGY
- Quantitative evidence for early metastatic seeding in colorectal cancer
- (2019) Zheng Hu et al. NATURE GENETICS
- Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer
- (2018) S Siena et al. ANNALS OF ONCOLOGY
- Cetuximab Combined With Induction Oxaliplatin and Capecitabine, Followed by Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer: SWOG 0713
- (2018) Cynthia Gail Leichman et al. Clinical Colorectal Cancer
- 3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial
- (2018) Timothy J Iveson et al. LANCET ONCOLOGY
- Preoperative radiotherapy or chemoradiotherapy in rectal cancer – Is survival improved? An update of the “Nordic” LARC study in non-resectable cancers
- (2018) Morten Brændengen et al. RADIOTHERAPY AND ONCOLOGY
- Surgical Treatment of Metastatic Colorectal Cancer
- (2018) Jeffery Chakedis et al. Surgical Oncology Clinics of North America
- Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
- (2018) Andrea Cercek et al. JAMA Oncology
- Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial
- (2017) Johan Erlandsson et al. LANCET ONCOLOGY
- Long-course oxaliplatin-based preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study
- (2016) K. Bujko et al. ANNALS OF ONCOLOGY
- Effect of Interval (7 or 11 weeks) Between Neoadjuvant Radiochemotherapy and Surgery on Complete Pathologic Response in Rectal Cancer: A Multicenter, Randomized, Controlled Trial (GRECCAR-6)
- (2016) Jérémie H. Lefevre et al. JOURNAL OF CLINICAL ONCOLOGY
- Surgical Management of Liver Metastases From Colorectal Cancer
- (2016) Mashaal Dhir et al. Journal of Oncology Practice
- Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum
- (2015) R. Glynne-Jones et al. BMC CANCER
- Chemotherapy for colorectal cancer in the elderly
- (2015) Jung Han Kim WORLD JOURNAL OF GASTROENTEROLOGY
- Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study
- (2014) Jean-François Bosset et al. LANCET ONCOLOGY
- Transanal endoscopic surgery in rectal cancer
- (2014) Xavier Serra-Aracil WORLD JOURNAL OF GASTROENTEROLOGY
- Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS, locally advanced rectal cancer (LARC): a randomized, multicenter, phase II trial SAKK 41/07
- (2012) D. Helbling et al. ANNALS OF ONCOLOGY
- Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients
- (2012) A. A. Argyriou et al. ANNALS OF ONCOLOGY
- Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04
- (2012) Samuel Y. Ngan et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Outcome of the ACCORD 12/0405 PRODIGE 2 Randomized Trial in Rectal Cancer
- (2012) Jean-Pierre Gérard et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of preoperative short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer
- (2012) M. Guckenberger et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Management of Rectal Cancer: Short- vs. Long-Course Preoperative Radiation
- (2008) Mohammed Mohiuddin et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Randomized Phase III Study Comparing Preoperative Radiotherapy With Chemoradiotherapy in Nonresectable Rectal Cancer
- (2008) Morten Brændengen et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started